sales@businessmarketinsights.com     UK: +442081254005
   
ORDER SUMMARY
LICENSE
PRICE
  • US Irritable Bowel Syndrome Treatment Market to 2027 - Country Analysis and Forecasts by Type (IBS with Diarrhea (IBS-D), IBS with Constipation (IBS-C), Mixed IBS (IBS-M)); Product (Rifaximin, Eluxadoline, Lubiprostone, Linaclotide, Others); Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Pharmacies)

  • TIPRE00009741 | Single User License | $3000
Single User License
$3000

Subtotal $3000

Grand Total $3000

Credit Card/Debit Card


(credit/debit card)